Dow Falls Nearly 150 Points On Losses For Merck, Walt Disney Stocks

Dow Jones
Oct 02

DJ Dow Falls Nearly 150 Points On Losses For Merck, Walt Disney Stocks

This article was automatically generated by MarketWatch using technology from Automated Insights.

The Dow Jones Industrial Average is declining Thursday morning with shares of Merck and Walt Disney seeing the biggest losses for the blue-chip average.

The Dow (Dow Jones Industrial Average) was most recently trading 144 points, or 0.3%, lower, as shares of Merck (Merck & Co. Inc.) and Walt Disney (Walt Disney Co.) have contributed to the index's intraday decline.

Merck's shares have declined $1.80, or 2.0%, while those of Walt Disney are down $1.83 (1.6%), combining for an approximately 22-point drag on the Dow.

Microsoft (Microsoft Corp.), Goldman Sachs (Goldman Sachs Group Inc.), and Verizon (Verizon Communications Inc.) are also contributing significantly to the decline.

A $1 move in any one of the 30 components of the Dow results in a 6.15-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

October 02, 2025 11:15 ET (15:15 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10